Intensive Insulin Therapy in Hospitalized Patients

TO THE EDITOR: I appreciated Qaseem and colleagues’ extensive review of in-hospital glucose targets (1). Perhaps I misunderstood, but I think that the stated target blood glucose level of 7.8 to 11.1 mmol/L (140 to 200 mg/dL) includes all patients. When I looked at the references, however, most of them seemed to discuss patients who are receiving nothing by mouth because they are critically ill, are postoperative, or have had recent neurologic events. Most of the time, if a hospitalized patient is eating, we in the medical community almost universally check the preprandial capillary glucose level. If it is 11.1 mmol/L (200 mg/dL), the postprandial blood glucose level would be higher and outside of the target range. I did not interpret Qaseem and colleagues’ article as suggesting that mealtime insulin coverage is not needed if the preprandial blood glucose level is less than 11.1 mmol/L ( 200 mg/dL). This is the interpretation of many of my colleagues. My understanding is that they are recommending that all blood glucose levels, both preprandial and postprandial, be less than 11.1 mmol/L ( 200 mg/dL); please clarify this recommendation.

[1]  M. Badminton,et al.  Liver transplantation from donors with acute intermittent porphyria. , 2011, Annals of internal medicine.

[2]  H. Alkadhi,et al.  Meta-analysis: Diagnostic Performance of Low-Radiation-Dose Coronary Computed Tomography Angiography , 2011, Annals of Internal Medicine.

[3]  D. Kansagara,et al.  Intensive Insulin Therapy in Hospitalized Patients: A Systematic Review , 2011, Annals of Internal Medicine.

[4]  P. Shekelle,et al.  Use of Intensive Insulin Therapy for the Management of Glycemic Control in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians , 2011, Annals of Internal Medicine.

[5]  Limin Peng,et al.  Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) , 2011, Diabetes Care.

[6]  Harlan M. Krumholz,et al.  Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease , 2010, Annals of Internal Medicine.

[7]  Mary T Korytkowski,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[8]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[9]  Roberto Delfini,et al.  Safety and Efficacy of Intensive Insulin Therapy in Critical Neurosurgical Patients , 2009, Anesthesiology.

[10]  E. Kuralay,et al.  Does continuous insulin therapy reduce postoperative supraventricular tachycardia incidence after coronary artery bypass operations in diabetic patients? , 2008, Journal of cardiothoracic and vascular anesthesia.

[11]  G. Van den Berghe,et al.  Intensive insulin therapy in high-risk cardiac surgery patients: evidence from the Leuven randomized study. , 2006, Seminars in thoracic and cardiovascular surgery.

[12]  Yingxing Wu,et al.  Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[13]  B. Riedel,et al.  Coronary revascularization: a procedure in transition from on-pump to off-pump? The role of glucose-insulin-potassium revisited in a randomized, placebo-controlled study. , 2002, Journal of cardiothoracic and vascular anesthesia.

[14]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[15]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[16]  G. Grunkemeier,et al.  Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. , 1999, The Annals of thoracic surgery.